The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

Arindam Datta1, Jessica Jackson2, Yaroslav I Morozov1

  • 1Department of Cancer Biology, Penn Center for Genome Integrity, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Ataxia Telangiectasia Mutated (ATM) kinase deficiency causes cancer and drug sensitivity. BRCA1-A complex loss in ATM-deficient cells restores drug resistance by enabling DNA end resection at damaged forks.

Area of Science:

  • DNA repair mechanisms
  • Cancer biology
  • Genetics

Background:

  • Ataxia Telangiectasia Mutated (ATM) kinase deficiency leads to cancer and drug hypersensitivity.
  • BRCA1-interacting protein A (BRCA1-A) complex or XRCC4/Ligase 4 deficiency confers resistance to Topoisomerase I or PARP1 inhibitors in ATM-deficient cells.
  • BRCA1-A complex may direct toxicity to DNA damaging agents in ATM-mutated cells via illegitimate end-joining.

Purpose of the Study:

  • To investigate the role of ATM inhibition in DNA damage response.
  • To elucidate the mechanism by which BRCA1-A complex influences drug sensitivity in ATM-deficient cells.
  • To identify key factors determining chemotherapy response in ATM-deficient cancers.

Main Methods:

  • Cellular assays to assess DNA damage recognition and repair.
  • SUMOylation and ubiquitination assays.
  • Chromatin accessibility and nuclease activity measurements.
  • Electron microscopy to visualize replication fork dynamics.
  • Drug sensitivity assays with Topoisomerase I inhibitors.

Main Results:

  • ATM inhibition triggers SUMO and ubiquitin-mediated BRCA1-A recognition of damaged forks, restricting end-resection and causing Topoisomerase I inhibitor hypersensitivity.
  • BRCA1-A deficient cells exhibit increased chromatin accessibility and nuclease activity at damaged forks, restoring DNA end resection and drug resistance.
  • ATM inhibition prevents replication fork reversal; loss of BRCA1-A restores fork reversal, generating substrates for end resection.

Conclusions:

  • BRCA1-A enforces a restrictive chromatin state to prevent the formation of DNA end resection substrates.
  • Replication fork reversal is a critical determinant of chemotherapy response in ATM-deficient cells.
  • Targeting BRCA1-A or modulating fork reversal may offer therapeutic strategies for ATM-deficient cancers.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication forks, one in...
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication forks, one in...